The Effects of Leucine Metabolites in Performance, Body Composition and Biochemical Markers of Muscle Damage

Resistance Training Clinical Trial

— LMET2IMPROVE  

Official title:

The Effects of β-hydroxy-β-methylbutyrate and Leucic Acid in Performance, Body Composition and Biochemical Markers

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03511092
• Other study ID #: LabFisiolBioqMLeu
• Status: Completed
• Phase: N/A
• Start date: May 29, 2017
• Est. completion date: October 28, 2017

Study information

• Verified date: February 2024
• Source: Faculdade de Motricidade Humana
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This study aimed to conduct a double-blind randomized pragmatic trial to evaluate the effects of off-the-shelf leucine metabolite supplements HMB-FA, HMB-Ca, alfa-HICA, on resistance training-induced changes in body composition, performance and biochemical markers of muscle damage. The investigators' working hypothesis is that so long as subjects adhered to a diet containing adequate energy and dietary protein, there would be no differences between those receiving the leucine metabolites - HMB-FA, HMB-Ca and alfa-HICA - when compared to a placebo consuming group.

Description:

This was a randomized, double blind, placebo-controlled study with additional control of diet. The investigators compared the effect of 8 weeks of supplementation with HMB-FA, HMB-Ca, or alfa-HICA on performance, body composition, and biochemical markers of muscle damage. The study involved fifty-three participants engaged in resistance training for at least one year (≥3 training sessions per week).

Performance measures - To evaluate aerobic performance an incremental test to volitional exhaustion was performed. Peak power and strength was assessed by maximum strength and the participants also performed a Wingate and vertical jump tests. Perceived performance and recovery was measured by the perceived recovery status scores in training days. This tool allowed to evaluate both fatigue, general muscle soreness, sleep quality, stress levels and mood throughout the study. Performance tests were performed at baseline, prior to the beginning of the study, and at the end of weeks 4 and 8, in a fed state (a meal replacement bar was provided to participants before the tests).

Body composition measures - To evaluate body composition a dual-energy X-ray absorptiometry (DXA) scan was performed; Muscle thickness was measured by ultrasonography; Total body water and both the extracellular water and intracellular water were assessed by bioelectrical impedance spectroscopy (BIS). These tests were performed at baseline and at the end of weeks 4 and 8, with participants reporting to the lab in a fasted state, refraining from exercise, alcohol or stimulant beverages for at least 8 h.

Biochemical markers of muscle damage - To assess biochemical markers (total testosterone and cortisol, creatine kinase, insulin-like growth factor 1, growth hormone), blood was collected at baseline and at the end of weeks 4 and 8, in a fasted state with participants also refraining from exercise, alcohol or stimulant beverages for at least 12 h.

Training protocol - The training program was designed according to the guidelines for hypertrophy type of resistance training for intermediate-trained individuals and consisted on 3 sessions per week during an 8-week period.

Statistics - sample size was calculated through an a priori power analysis (G*Power Version 3.1.9.2, Heinrich Heine Universitat Dusseldorf, Germany), based on FFM changes from previous studies and power of 0.80. Statistical analysis will be performed using IBM SPSS statistics version 22.0 (IBM, Chicago, Illinois, USA). Normality of the distribution of variables will be tested by Shapiro-Wilk test. Baseline characteristics between groups were analyzed by a 1-way analysis of variance (ANOVA) since normality was observed. Time and time x group interactions will be evaluated by repeated-measures ANOVA. The equality of the matrix of variance and sphericity will be explored with the Levene F test and Mauchly's test, respectively. Overall significance level for α was set at p ≤ 0.05.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 53
• Est. completion date: October 28, 2017
• Est. primary completion date: October 28, 2017
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Male
• Age group: 18 Years to 45 Years

Eligibility

Inclusion Criteria:

• Resistance training subjects for more than one year

Exclusion Criteria:

• Individuals taking any type of drug, medicines or supplements that may enhance body composition or performance, 1 months prior to the research.

• Smokers

• Clinical diagnose of a disease that might compromise tolerance to the supplements or influence body composition and performance

• More than 25% body fat

• Individuals involved in similar research 3 months prior to the study

Related Conditions & MeSH terms

• Resistance Training

Intervention

Dietary Supplement:
• HMB-FA
One gram of HMB-FA was ingested before exercise, and two grams were ingested at subsequent meals (1 g per meal). At rest days supplement was administered 1 g per meal. The total duration of the intervention was 8 weeks.
• HMB-Ca
One gram of HMB-Ca was ingested before exercise, and two grams were ingested at subsequent meals (1 g per meal). At rest days supplement was administered 1 g per meal. The total duration of the intervention was 8 weeks.
• alfa-HICA
Five hundred miligram of alfa-HICA was ingested before exercise, and one gram was ingested at subsequent meals (500 mg per meal). At rest days supplement was administered 500 mg per meal. The total duration of the intervention was 8 weeks.

Other:
• Placebo comparator
One gram of magnesium stearate was ingested before exercise, and two grams were ingested at subsequent meals (1 g per meal). At rest days placebo was administered 1 g per meal. The total duration of the intervention was 8 weeks.

Locations

Country	Name	City	State
Portugal	Faculty of Human Kinetics	Lisbon

Sponsors (1)

Lead Sponsor	Collaborator
Faculdade de Motricidade Humana

Country where clinical trial is conducted

Portugal, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Change of maximum strength	kg	Baseline, week 4 and week 8
Primary	Change of peak power	Watt	Baseline, week 4 and week 8
Primary	Change of jump height	cm	Baseline, week 4 and week 8
Primary	Change of power	Watt	Baseline, week 4 and week 8
Primary	Change of muscle thickness	mm	Baseline, week 4 and week 8
Primary	Change of fat free mass	kg	Baseline, week 4 and week 8
Primary	Change of fat mass		Baseline, week 4 and week 8
Primary	Change of body water	kg	Baseline, week 4 and week 8
Secondary	Change of biochemical markers of muscle damage	total testosterone and cortisol, creatine kinase, insulin-like growth factor 1, growth hormone	Baseline, week 4 and week 8
Secondary	Oxygen uptake	mL.kg-1.min-1	Baseline and week 8
Secondary	Heart rate	beats.min-1	Baseline and week 8